reviewNature Reviews Drug DiscoveryApr 25, 2025Closed access

GLP-1-based therapies for diabetes, obesity and beyond

Lunenfeld-Tanenbaum Research Institute

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

137
total citations
FWCI
124.53
Percentile
100%
References
184
Citations per year

Authors

1

Topics & keywords

Keywords
  • Medicine
  • Diabetes mellitus
  • Obesity
  • Intensive care medicine
  • Pharmacology
  • Internal medicine
  • Endocrinology
UN Sustainable Development Goals
  • Zero hunger
No related works found for this paper.